CFBK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CF Bankshares Inc (CFBK) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The business fundamentals and Q1 2026 results are improving, but the technical setup is weak and there is no proprietary buy signal. Since the user is impatient and does not want to wait for a better entry, I would still not call this a buy today; the better call is to hold and wait for a cleaner technical entry or stronger momentum confirmation.
CFBK is trading near 27.39, essentially flat versus the prior close of 27.36, while the broader market was down. The trend is mixed to weak: MACD histogram is negative at -0.283, although it is contracting, which suggests downside momentum is easing. RSI_6 at 29.869 is near oversold territory but not giving a strong reversal confirmation. Moving averages are converging, which usually signals indecision rather than a clear uptrend. Price is sitting just above S1 support at 27.17, with deeper support at 26.33 and resistance at 28.53, then 29.90. The short-term stock trend data also leans soft, with a 40% chance of a -1.7% move next day and roughly flat-to-slightly negative expectations over the following week and month. Overall: no clear technical buy signal today.
Revenue increased 6.73% YoY to $13.18 million. Core commercial loan growth was strong at $45 million in the quarter, an annualized 15% growth rate. Non-interest income rose 23.3% YoY, helped by higher service charges on deposits. Credit quality appears manageable, with nonaccrual loans at 1.14% of total loans. Capital levels are solid, with a Tier 1 leverage ratio of 11.76% and total capital ratio of 15.15%. Piper Sandler recently initiated coverage with an Overweight rating and raised its price target to $34 from $29, citing an attractive turnaround, above-peer organic balance sheet growth, margin expansion potential, and discounted valuation.
There is no options sentiment data to support a bullish trade view. Hedge funds and insiders are both neutral with no significant recent activity. The stock does not have an AI Stock Picker signal or a recent SwingMax signal, so there is no proprietary catalyst. The latest financial snapshot shows net income reported as 0 and down 100% YoY, which is inconsistent with the earnings release and suggests some data noise, but it still weakens confidence in the current read. Technically, momentum is not yet constructive: MACD remains negative, price is below the pivot of 28.534, and the stock is still close to support rather than breaking above resistance. Comparable candlestick pattern analysis also points to weak near-term performance expectations.
Latest quarter: Q1 2026. The company showed solid top-line and earnings improvement in the reported news flow, with net income up 13% YoY to $5.0 million and diluted EPS up 13% YoY to $0.77. Revenue increased 6.73% YoY to $13.18 million. Loan growth was a key strength, with $45 million in net core commercial loan growth, annualized at 15%. Non-interest income rose 23.3% YoY. Credit metrics and capital ratios were healthy, with nonaccrual loans at 1.14% of total loans and strong regulatory capital. Overall, the latest quarter suggests improving growth trends and a constructive turnaround, despite the conflicting snapshot showing net income at 0.
Piper Sandler initiated coverage on 2026-04-02 with an Overweight rating and a $34 price target, up from $29. The bullish view is based on CF Bankshares' turnaround progress, organic balance sheet growth, modest net interest margin expansion, and discounted valuation. Wall Street pros appear constructive overall, with clear upside framing, while the main caution is that the stock still needs technical confirmation before it becomes an attractive near-term entry.
